Skye Bioscience, Inc. Stock-Based Compensation
Skye Bioscience, Inc. (SKYE) reported Stock-Based Compensation of $2.77 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- Skye Bioscience, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $1.27M, a 37.47% decline year-over-year.
- Skye Bioscience, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.50M, a 32.01% decline year-over-year.
- Skye Bioscience, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.62M, a 22.53% decline year-over-year.
- Skye Bioscience, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.91M, a 0.39% decline year-over-year.
- Skye Bioscience, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $7.77M, a 6.61% decline from fiscal 2024.
- Skye Bioscience, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $8.32M, a 742.27% increase from fiscal 2023.
- Skye Bioscience, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $987.51K, a 56.99% increase from fiscal 2022.
- Skye Bioscience, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $629.03K, a 27.63% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $2.77M 10-Q · filed 2026-08-14 | $4.39M derived: sum of 3 quarters · filed 2026-08-14 | $6.30M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $1.50M 10-Q · filed 2026-05-11 | $3.12M derived: sum of 2 quarters · filed 2026-05-11 | $5.03M derived: sum of 3 quarters · filed 2026-05-11 | $7.06M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $3.53M derived: sum of 2 quarters · filed 2026-03-10 | $5.57M derived: sum of 3 quarters · filed 2026-08-14 | $7.77M 10-K · filed 2026-03-10 | |
| 2025-09-30 | $1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $3.95M derived: sum of 2 quarters · filed 2026-08-14 | $6.15M 10-Q · filed 2025-11-10 | $8.24M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $4.24M 10-Q · filed 2026-08-14 | $6.32M derived: sum of 3 quarters · filed 2026-08-14 | $8.25M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $2.20M 10-Q · filed 2026-05-11 | $4.29M derived: sum of 2 quarters · filed 2026-05-11 | $6.21M derived: sum of 3 quarters · filed 2026-05-11 | $8.04M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | $2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $4.01M derived: sum of 2 quarters · filed 2026-03-10 | $5.84M derived: sum of 3 quarters · filed 2026-03-10 | $8.32M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $1.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $3.75M derived: sum of 2 quarters · filed 2025-11-10 | $6.23M 10-Q · filed 2025-11-10 | $6.82M derived: sum of 4 quarters · filed 2025-11-10 | |
| 2024-06-30 | $1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $4.31M 10-Q · filed 2025-08-07 | $4.90M derived: sum of 3 quarters · filed 2025-08-07 | $5.06M derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $2.48M 10-Q · filed 2025-05-08 | $3.07M derived: sum of 2 quarters · filed 2025-05-08 | $3.23M derived: sum of 3 quarters · filed 2025-05-08 | $3.33M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $592.85K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $753.06K derived: sum of 2 quarters · filed 2025-03-20 | $855.93K derived: sum of 3 quarters · filed 2025-03-20 | $987.51K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $160.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $263.08K derived: sum of 2 quarters · filed 2024-11-07 | $394.66K 10-Q · filed 2024-11-07 | $597.84K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $102.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $234.45K 10-Q · filed 2024-08-09 | $437.64K derived: sum of 3 quarters · filed 2024-08-09 | $581.76K derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | $131.58K 10-Q · filed 2024-05-10 | $334.76K derived: sum of 2 quarters · filed 2024-05-10 | $478.89K derived: sum of 3 quarters · filed 2024-05-10 | $623.25K derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | $203.19K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $347.31K derived: sum of 2 quarters · filed 2024-03-22 | $491.67K derived: sum of 3 quarters · filed 2024-03-22 | $629.03K 10-K · filed 2024-03-22 | |
| 2022-09-30 | $144.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $288.49K derived: sum of 2 quarters · filed 2023-11-14 | $425.85K 10-Q · filed 2023-11-14 | $547.80K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $144.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $281.72K 10-Q · filed 2023-08-07 | $403.68K derived: sum of 3 quarters · filed 2023-08-07 | $892.65K derived: sum of 4 quarters · filed 2023-08-07 | |
| 2022-03-31 | $137.36K 10-Q · filed 2023-05-12 | $259.31K derived: sum of 2 quarters · filed 2023-05-12 | $748.28K derived: sum of 3 quarters · filed 2023-05-12 | $859.98K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $121.95K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $610.93K derived: sum of 2 quarters · filed 2023-03-31 | $722.63K derived: sum of 3 quarters · filed 2023-03-31 | $869.21K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $488.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $600.67K derived: sum of 2 quarters · filed 2022-11-14 | $747.25K 10-Q · filed 2022-11-14 | $808.78K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $111.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $258.28K 10-Q · filed 2022-08-15 | $319.81K derived: sum of 3 quarters · filed 2022-08-15 | $468.17K derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $146.58K 10-Q · filed 2022-05-06 | $208.11K derived: sum of 2 quarters · filed 2022-05-06 | $356.47K derived: sum of 3 quarters · filed 2022-05-06 | $385.18K derived: sum of 4 quarters · filed 2022-05-06 | |
| 2020-12-31 | $61.53K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $209.89K derived: sum of 2 quarters · filed 2022-03-28 | $238.60K derived: sum of 3 quarters · filed 2022-03-28 | $302.74K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $148.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $177.07K derived: sum of 2 quarters · filed 2021-11-10 | $241.22K 10-Q · filed 2021-11-10 | $406.99K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $28.71K 10-Q · filed 2020-08-13 | $92.85K 10-Q · filed 2021-08-06 | $258.62K derived: sum of 3 quarters · filed 2021-05-07 | $428.73K derived: sum of 4 quarters · filed 2021-05-07 | |
| 2020-03-31 | $64.14K 10-Q · filed 2021-05-07 | $229.91K derived: sum of 2 quarters · filed 2021-05-07 | $400.02K derived: sum of 3 quarters · filed 2021-05-07 | $573.10K derived: sum of 4 quarters · filed 2021-05-07 | |
| 2019-12-31 | $165.77K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $335.88K derived: sum of 2 quarters · filed 2021-03-02 | $508.96K derived: sum of 3 quarters · filed 2021-03-02 | $680.46K 10-K · filed 2021-03-02 | |
| 2019-09-30 | $170.11K 10-Q · filed 2019-11-14 | $343.19K derived: sum of 2 quarters · filed 2020-08-13 | $514.68K 10-Q · filed 2020-11-06 | $704.92K derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-06-30 | $173.08K 10-Q · filed 2020-08-13 | $344.58K 10-Q · filed 2020-08-13 | $534.82K derived: sum of 3 quarters · filed 2020-08-13 | $689.33K derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | $171.49K 10-Q · filed 2020-05-08 | $361.73K derived: sum of 2 quarters · filed 2020-05-08 | $516.24K derived: sum of 3 quarters · filed 2020-05-08 | $616.85K derived: sum of 4 quarters · filed 2020-05-08 | |
| 2018-12-31 | $190.24K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $344.75K derived: sum of 2 quarters · filed 2020-03-23 | $445.35K derived: sum of 3 quarters · filed 2020-03-23 | $674.96K 10-K · filed 2020-03-23 | |
| 2018-09-30 | $154.51K 10-Q · filed 2019-11-14 | $255.11K derived: sum of 2 quarters · filed 2019-11-14 | $484.72K 10-Q · filed 2019-11-14 | $636.89K derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $100.60K 10-Q · filed 2019-08-09 | $100.60K 10-Q · filed 2018-08-10 | $330.21K 10-Q · filed 2019-08-09 | $482.38K derived: sum of 3 quarters · filed 2019-08-09 | $634.55K derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $229.61K 10-Q · filed 2019-05-10 | $381.78K derived: sum of 2 quarters · filed 2019-05-10 | $533.95K derived: sum of 3 quarters · filed 2019-05-10 | $686.12K derived: sum of 4 quarters · filed 2019-05-10 | |
| 2017-12-31 | $152.17K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $304.34K derived: sum of 2 quarters · filed 2019-03-14 | $456.51K derived: sum of 3 quarters · filed 2019-03-14 | $608.68K 10-K · filed 2019-03-14 | |
| 2017-09-30 | $152.17K 10-Q · filed 2018-11-14 | $304.34K derived: sum of 2 quarters · filed 2018-11-14 | $456.51K 10-Q · filed 2018-11-14 | $618.06K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $152.17K 10-Q · filed 2018-08-10 | $304.34K 10-Q · filed 2018-08-10 | $465.88K derived: sum of 3 quarters · filed 2018-08-10 | $647.49K derived: sum of 4 quarters · filed 2018-08-10 | |
| 2017-03-31 | $152.17K 10-Q · filed 2018-05-15 | $313.71K derived: sum of 2 quarters · filed 2018-05-15 | $495.32K derived: sum of 3 quarters · filed 2018-05-15 | $676.93K derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | $161.54K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $343.15K derived: sum of 2 quarters · filed 2018-03-19 | $524.76K derived: sum of 3 quarters · filed 2018-03-19 | $706.37K 10-K · filed 2018-03-19 | |
| 2016-09-30 | $181.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $363.21K derived: sum of 2 quarters · filed 2017-11-14 | $544.82K 10-Q · filed 2017-11-14 | $695.18K derived: sum of 4 quarters · filed 2017-11-14 | |
| 2016-06-30 | $181.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $363.22K 10-Q · filed 2017-08-11 | $513.57K derived: sum of 3 quarters · filed 2017-08-11 | $517.86K derived: sum of 4 quarters · filed 2017-08-11 | |
| 2016-03-31 | $181.61K 10-Q · filed 2017-05-12 | $331.97K derived: sum of 2 quarters · filed 2017-05-12 | $336.25K derived: sum of 3 quarters · filed 2017-05-12 | $459.60K derived: sum of 4 quarters · filed 2017-05-12 | |
| 2015-12-31 | $150.36K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $154.64K derived: sum of 2 quarters · filed 2017-03-10 | $278.00K derived: sum of 3 quarters · filed 2017-03-10 | $414.34K 10-K · filed 2017-03-10 | |
| 2015-09-30 | $4.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $127.64K derived: sum of 2 quarters · filed 2016-11-09 | $263.99K 10-Q · filed 2016-11-09 | ||
| 2015-06-30 | $123.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $259.70K 10-Q · filed 2016-08-12 | |||
| 2015-03-31 | $136.35K 10-Q · filed 2016-05-13 | ||||
| 2014-12-31 | $10.77K 10-K · filed 2016-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |